<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd"><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Neural Plast</journal-id><journal-id journal-id-type="publisher-id">NP</journal-id><journal-title-group><journal-title>Neural Plasticity</journal-title></journal-title-group><issn pub-type="ppub">2090-5904</issn><issn pub-type="epub">1687-5443</issn><publisher><publisher-name>Hindawi Publishing Corporation</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">19266049</article-id><article-id pub-id-type="pmc">2650089</article-id><article-id pub-id-type="doi">10.1155/2009/516328</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title>Behavioral Consequences of Delta-Opioid                         Receptor  Activation in the Periaqueductal Gray of Morphine                         Tolerant Rats</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Morgan</surname><given-names>Michael M.</given-names></name><xref ref-type="aff" rid="I1"><sup>1</sup></xref><xref ref-type="corresp" rid="cor1">*</xref></contrib><contrib contrib-type="author"><name><surname>Ashley</surname><given-names>Michelle D.</given-names></name><xref ref-type="aff" rid="I1"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>Ingram</surname><given-names>Susan L.</given-names></name><xref ref-type="aff" rid="I1"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>Christie</surname><given-names>MacDonald J.</given-names></name><xref ref-type="aff" rid="I2"><sup>2</sup></xref></contrib></contrib-group><aff id="I1"><sup>1</sup>Department of Psychology, Washington State University Vancouver, 14204 NE Salmon Creek Avenue, Vancouver, WA 98686, USA</aff><aff id="I2"><sup>2</sup>Brain and Mind Research Institute, The University of Sydney, NSW 2006, Australia</aff><author-notes><corresp id="cor1">*Michael M. Morgan: <email>morgan@vancouver.wsu.edu</email></corresp><fn fn-type="other"><p>Recommended by Thelma A. Lovick</p></fn></author-notes><pub-date pub-type="ppub"><year>2009</year></pub-date><pub-date pub-type="epub"><day>25</day><month>2</month><year>2009</year></pub-date><volume>2009</volume><elocation-id>516328</elocation-id><history><date date-type="received"><day>2</day><month>6</month><year>2008</year></date><date date-type="rev-recd"><day>5</day><month>9</month><year>2008</year></date><date date-type="accepted"><day>11</day><month>12</month><year>2008</year></date></history><permissions><copyright-statement>Copyright &#x000a9; 2009 Michael M. Morgan et al.</copyright-statement><copyright-year>2009</copyright-year><license license-type="open-access"><license-p>This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><abstract><p>Chronic morphine administration shifts delta-opioid receptors (DORs) from the cytoplasm to the plasma membrane. Given that microinjection of morphine into the PAG produces antinociception, it is hypothesized that the movement of DORs to the membrane will allow antinociception to the DOR agonist deltorphin II as a way to compensate for morphine tolerance. Tolerance was induced by twice daily injections of morphine (5, 10, or 20 mg/kg, subcutaneous) for 3.5 days. Microinjection of deltorphin into the vPAG 6 hours after the last morphine injection produced a mild antinociception that did not vary in a consistent manner across morphine pretreatment doses or nociceptive tests. In contrast, deltorphin caused a decrease in activity in morphine tolerant rats that was associated with lying in the cage. The decrease in activity and change in behavior indicate that chronic morphine administration alters DORs in the vPAG. However, activation of these receptors does not appear to compensate for the decrease in antinociception caused by morphine tolerance.</p></abstract></article-meta></front><body><sec sec-type="section" id="sec1"><title>1. Introduction</title><p>Opioid receptors in the periaqueductal gray(PAG) contribute to a wide range of behaviors. These include nociceptivemodulation, cardiovascular regulation, thermoregulation, and locomotor activity[<xref ref-type="bibr" rid="B1">1</xref>&#x02013;<xref ref-type="bibr" rid="B5">5</xref>]. Although mu-opioid receptors (MOR) are known to contribute toPAG mediated antinociception [<xref ref-type="bibr" rid="B6">6</xref>, <xref ref-type="bibr" rid="B7">7</xref>], less is known about the contribution of delta-opioid receptors(DORs). Although antinociception has been produced by the administration of DORagonists into the PAG, these effects are mild compared to the antinociceptionproduced by MOR agonists [<xref ref-type="bibr" rid="B8">8</xref>&#x02013;<xref ref-type="bibr" rid="B10">10</xref>].</p><p>DORs are particularly interesting because the expressionof these receptors is surprisingly dynamic. Chronic treatment with morphinecauses the spinal density of DORs to shift from the cytoplasm to the plasmamembrane [<xref ref-type="bibr" rid="B11">11</xref>, <xref ref-type="bibr" rid="B12">12</xref>]. A similar shift in DORs from the cytoplasm [<xref ref-type="bibr" rid="B13">13</xref>] to the plasma membrane appears to occur in the PAG. Swim stress causes anincrease in DOR density in the plasma membrane of PAG neurons [<xref ref-type="bibr" rid="B14">14</xref>]. <italic>In vitro</italic> recordings show that DOR agonists do not alterGABAergic synaptic transmission in PAG neurons from drug-naive animals [<xref ref-type="bibr" rid="B15">15</xref>&#x02013;<xref ref-type="bibr" rid="B17">17</xref>], but inhibit GABAergic IPSCs in mice treated chronically withmorphine [<xref ref-type="bibr" rid="B18">18</xref>].</p><p>The behavioral significance of enhanced DORexpression in the PAG has not been characterized. The increased expression ofDOR in the PAG of morphine tolerant rats could be a compensatory mechanism forthe loss of antinociception at the mu-opioid receptor. Increased expression ofDORs in the spinal cord has been shown to enhance the antinociceptive effect ofintrathecal administration of the DOR agonist deltorphin II [<xref ref-type="bibr" rid="B19">19</xref>].</p><p>The objective of the present study was todetermine the behavioral consequences of activating DORs in the PAG followinginduction of morphine tolerance. Given the widespread effects mediated by thePAG, mobilization of DORs to the plasma membrane could contribute to a widerange of behaviors. The enhanced antinociceptive effects of DOR agonists at thespinal level [<xref ref-type="bibr" rid="B19">19</xref>] suggest that the administration of DOR agonists into the vPAG ofmorphine tolerant rats will produce antinociception. This hypothesis will betested by examining the antinociceptive and locomotor effects of microinjectingthe DOR agonist deltorphin into the vPAG of rats made tolerant to morphine.</p></sec><sec sec-type="section" id="sec2"><title>2. Methods</title><p>Male Sprague-Dawley rats (240&#x02013;360 g) wereanesthetized with pentobarbital and implanted with a guide cannula aimed at theventrolateral PAG using stereotaxic techniques (from lambda: AP  =  +1.2 mm, ML  =  0.6 mm, and DV  =  &#x02212;4.6 mm). The guide cannula was 9 mm long and affixed to twoscrews in the skull with dental cement. Rats were handled daily for one weekfollowing surgery. All injections and testing were conducted duringthe dark phase of a 12-hour light/dark cycle in a dimly illuminated room. Experiments were conducted in accordance with the National Institutes of HealthGuide for the Care and Use of Laboratory animals. Efforts were made to minimizethe number and potential suffering of the experimental subjects.</p><sec sec-type="subsection" id="subsec2.1"><title>2.1. Materials</title><p>Nociceptionwas assessed using the hot plate, tail withdrawal, and formalin tests. The hot-platetest (IITC, Woodland Hills, Calif, USA) consisted of measuring the latency fora rat to lick a hind paw when placed on a 52&#x000b0;C plate. Tail withdrawal measured the latency tomove the tail when placed in 52&#x000b0;C water. The formalin test consisted of ratingpain behavior on a 0&#x02013;3 scale followinginjection of formalin (2% in 50 ul) into the plantar surface of the hind paw [<xref ref-type="bibr" rid="B20">20</xref>]. The values on thisscale are 0  =  normal behavior; 1  =  paw touches the ground without bearingweight; 2  =  paw does not touch the ground; 3  =  paw is above the ground andlicked.</p></sec><sec sec-type="subsection" id="subsec2.2"><title>2.2. Microinjection Procedure</title><p>Fourdays after surgery, an injection cannula was inserted through the guidecannula, but no drug was injected. This process habituates rats to theinjection procedure and diminishes behavioral effects produced by cell damageon the test day. Testing began one week following surgery, deltorphin II (1 <italic>&#x003bc;</italic>g/0.5 <italic>&#x003bc;</italic>l)or saline was microinjected into the vPAG. An 11 mm injection cannula wasinserted into the guide cannula while the rat was gently restrained by hand. The injection cannula extended 2 mm beyond the end of the guide cannula. Drugswere injected at a rate of 0.1 ul/10 s. The injection cannula remained in placean additional 20 seconds to minimize drug flow up the cannula track. The styletwas reinserted into the guide cannula and the rat was returned to its homecage.</p><p><statement id="head1"><title>Experiment 1. Repeated Morphine Injections</title><p>The objective of this experiment was todetermine the behavioral effects of microinjecting deltorphin into the vPAG inrats made tolerant to repeated subcutaneous injections of morphine. Morphine(5, 10, or 20 mg/kg) or saline (1 ml/kg)was administered twice a day (at 9:30 and 15:00) for 3.5 days. Nociception was assessed withthe hot plate and tail flick tests 30 minutes after the injection on trials 1and 7, but not after injections on trials 2&#x02013;6. This procedurelimits changes in nociception from repeated testing [<xref ref-type="bibr" rid="B21">21</xref>, <xref ref-type="bibr" rid="B22">22</xref>]. Six hours after the last subcutaneous injection, all rats wereinjected with deltorphin (1 <italic>&#x003bc;</italic>g/0.5 <italic>&#x003bc;</italic>l) into the vPAG. Nociception was assessedusing the hot-plate test 20 minutes later. A subset of these rats was testedagain on the hot plate 50 minutes after deltorphin administration (<italic>N</italic>  =  9, 5,10, and 8 for groups tested with saline, 5, 10, and 20 mg/kg of morphine, resp.). Nociception was assessed using the formalin test in the other rats (<italic>N</italic>  =  8, 6, and9 for groups tested with saline, 10, and 20 mg/kg of morphine, resp.).</p><p>Locomotor activity was assessed for 30 minutesbeginning immediately after the 20 minutes hot-plate test. Activitywas assessed by placing the rat into a chamber (25.1  &#x000d7;  47 cm) with 7 photobeamsspaced 5.1 cm apart (San Diego Instruments, San Diego, Calif, USA). The averagenumber of photobeams disrupted each minute was measured and averaged over 10minute intervals for 30 minutes. The behavior of the rat was examined every 5 minutes during thelocomotor test in an attempt to determine the reason for the changes inlocomotion (e.g., grooming, sleeping, and freezing). Normal behavior wasdefined as walking, sniffing, and grooming.</p></statement></p><p><statement id="head2"><title>Experiment 2. Continuous Morphine Administration</title><p>Rats were surgically implanted with a guidecannula aimed at the vPAG as described in Experiment 1. One week later,tolerance was induced by implanting two 75 mg morphine pellets under the skinof the upper back while rats were briefly anesthetized with halothane. Controlrats were implanted with two placebo pellets. Nociception was assessed usingthe hot-plate test 2 hours following pellet implantation.</p><p>Rats were returned to the test room 3 days afterpellet implantation and allowed to habituate for 30 minutes. Nociception wasassessed at the end of this period using the hot-plate test to determinewhether tolerance had developed. Following this baseline test, both morphineand placebo-treated rats were injected with deltorphin (1 ug/0.5 ul) into thevPAG. Rats were returned to their cage immediately following the injection. Nociception was assessed using the hot-plate test 30 and 60 minutes after thedeltorphin microinjection.</p></statement></p></sec><sec sec-type="subsection" id="subsec2.3"><title>2.3. Histology</title><p>Following testing, ratswere given an overdose of halothane (Sigma, St. Louis, Mo, USA). Themicroinjection site was marked by injecting cresyl violet (0.2 <italic>&#x003bc;</italic>l) into the PAG. The brain was removed, placedin formalin (10%), sectioned coronally (50 <italic>&#x003bc;</italic>m), and viewed under a microscope to localizethe injection site [<xref ref-type="bibr" rid="B23">23</xref>]. Only rats withinjection sites in or immediately adjacent to the vPAG were included in dataanalysis.</p></sec><sec sec-type="subsection" id="subsec2.6"><title>2.4. Data Analysis</title><p>The effects of morphine pretreatment were compared tosaline or placebo-treated controls using a <italic>t</italic>-test or analysis ofvariance. The Bonferroni and Tukey tests were used for post hoc comparisons. Statistical significance was defined as a probability of less than .05.</p></sec></sec><sec sec-type="section" id="sec3"><title>3. Results</title><p><statement id="head4"><title>Experiment 1. Repeated Morphine Injections</title><p>Systemic administration of high doses of morphine (5,10, and 20 mg/kg) produced maximal antinociception on trial 1 (see <xref ref-type="fig" rid="fig1">Figure 1</xref>). Asignificant decrease in antinociception was evident with repeatedadministration from trial 1 to 7 (F(1,56) = 53.446, <italic>P</italic>  &#x0003c;  .05). Themagnitude of the decrease in antinociception was dose dependent (F(3,56) = 5.536, <italic>P</italic>  &#x0003c;  .05). That is, the lowest dose (5 mg/kg) produced theleast antinociception and the highest dose (20 mg/kg) produced the greatestantinociception in morphine tolerant rats.</p><p>Microinjection of deltorphin into the vPAG ofmorphine naive ratsproduced a slight increase in hot-plate latency. Rats pretreated with salineshowed a significant increase in hot-plate latency following microinjection ofdeltorphin from 10.8 (see trial 7 in <xref ref-type="fig" rid="fig1">Figure 1</xref>) to 14.5 seconds (20-minute test in <xref ref-type="fig" rid="fig2">Figure 2</xref>)(one-tailed <italic>t</italic>(18)  =  1.925, <italic>P</italic>  &#x0003c;  .05).</p><p>The effect of microinjecting deltorphin into thevPAG of morphine tolerant rats varied with the pretreatment dose (see <xref ref-type="fig" rid="fig2">Figure 2</xref>). A 2  &#x000d7;  2 ANOVA revealed a significant difference in hot-plate latencybetween the pretreatment groups (F(3,84)  =  3.203, <italic>P</italic>  &#x0003c;  .05), but nodifference in hot-plate latency between the 20- and 50-minute tests (F(1,84)  =  0.866; <italic>P</italic>  &#x0003e;  .05). The difference between groups was caused by a slight increase in the hot-platelatency of rats pretreated with 20 mg/kg of morphine and a slight decrease inlatency in rats pretreated with 10 mg/kg (see <xref ref-type="fig" rid="fig2">Figure 2</xref>). Although thedifference between these groups was statistically significant (Bonferroni, <italic>t</italic>  =  2.420, <italic>P</italic>  &#x0003c;  .05), neither the 10 mg/kg (<italic>t</italic>  =  0.96 and 1.15 for 20 and 50minutes, resp.) nor the 20 mg/kg (<italic>t</italic>  =  1.49 and 0.87 for 20 and 50 minutes, resp.)groups differed from the saline-pretreated group. Moreover, these changes innociception were quite small compared to the antinociception produced bysystemic administration of morphine on trial 7 (26.2 &#x000b1; 2.7 and 31.3 &#x000b1; 2.7 secondsfollowing 10 and 20 mg/kg doses of morphine).</p><p>A similar difference between pretreatment groups was evidentwhen nociception was assessed with the tail flick test 50 minutes afterdeltorphin administration (F(2,52)  =  8.699, <italic>P</italic>  &#x0003c;  .05). Microinjectionof deltorphin into the PAG of rats pretreated with 20 mg/kg of morphine causeda small, but significant, increase in tail flick latency (4.4 &#x000b1; 0.2 seconds)compared to rats pretreated with saline (3.5 &#x000b1; 0.2 seconds) or 10 mg/kg ofmorphine (3.4 &#x000b1; 0.2 seconds) (Tukey test, <italic>P</italic>  &#x0003c;  .05 for bothcomparisons).</p><p>Nociception was assessed using the formalin testin the rats not tested on the hot plate at 50 minutes. Formalin was injected 5minutes following the 20 minute hot-plate test so the first and second phases [<xref ref-type="bibr" rid="B20">20</xref>] could be assessed 25&#x02013;29 and 40&#x02013;44 minutes aftermicroinjection of deltorphin. In contrast to the hot-plate test, pain ratingson the formalin test did not differ between the pretreatment groups on eitherthe first (mean  ratings  =  1.65, 1.60, and 1.73) or the second (mean ratings  =  0.40, 0.63, and 0.67) phases (F(2,20)  =  0.272, <italic>P</italic>  =  .76).</p><p>Locomotor activity was assessed during the 30minutes following the 20 minute hot-plate test in the subset of rats notinjected with formalin. Microinjection of deltorphin into the vPAG caused asignificant decrease in activity in the morphine compared to the saline-pretreatedrats (F(2,29)  =  6.84, <italic>P</italic>  &#x0003c;  .05). This decrease was similar in ratspretreated with 10 and 20 mg/kg of morphine (see <xref ref-type="fig" rid="fig3">Figure 3</xref>). The greatestdecrease in activity was evident at the latest time period (41&#x02013;50 minutes) forboth pretreatment groups.</p><p>The decrease in activity was accompanied by achange in behavior in which rats tended to crouch or lie down in the activitychamber. An increase in the number of rats crouching or lying increased in ratspretreated with 10 and 20 mg/kg of morphine beginning approximately 25 minutes after the deltorphinmicroinjection (see <xref ref-type="table" rid="tab1">Table 1</xref>). This shift in the number of rats displayingnormal exploratory behavior to crouching and lying increased further during thelast 15 minutes of the test (40&#x02013;54 minutes afterthe deltorphin microinjection).</p></statement></p><p><statement id="head5"><title>Experiment 2. Continuous Morphine Administration</title><p>Implantation of morphine pellets produced anincrease in hot-plate latency compared to placebo-treated rats when assessed at1 hour (36.1 &#x000b1; 3.9 versus 20.5 &#x000b1; 2.4 seconds; <italic>t</italic>(8)  =  3.865, <italic>P</italic>  &#x0003c;  .05). Tolerance to the antinociceptive effect of morphine was evident by day 4 asindicated by a decrease in hot-plate latency to 18.8 &#x000b1; 1.8 seconds. Microinjection of deltorphin into the PAG caused a modest, but significant,increase in hot-plate latency compared to baseline latency (F(2,16)  =  5.806, <italic>P</italic>  &#x0003c;  .05). Although the baseline hot-plate latency for rats treated withmorphine pellets was greater than in placebo-treated rats (see <xref ref-type="fig" rid="fig4">Figure 4</xref>), thisdifference did not reach statistical significance using the Bonferroni test (<italic>t</italic>  =  1.482 nanoseconds). However, microinjection of deltorphin into the vPAG ofplacebo-treated rats caused a significant increase in hot-plate latency at the60-minute time point compared to the baseline (Bonferroni, <italic>t</italic>  =  3.044. <italic>P</italic>  &#x0003c;  .05). There was no difference in mean hot-plate latency following deltorphinadministration between morphine and placebo-treated rats (F(1,8)  =  0.791, <italic>P</italic>  &#x0003e;  .05), suggestingthat deltorphin administration did not increase antinociception beyond what wasalready present in rats with morphine pellets.</p></statement></p></sec><sec sec-type="section" id="sec4"><title>4. Discussion</title><p>Thepresent data demonstrate that repeated morphine administration alters the responseof vPAG neurons to the DOR agonist deltorphin. Although PAG neurons contributeto a wide range of behaviors [<xref ref-type="bibr" rid="B24">24</xref>], the change in responseto deltorphin microinjection was specific to locomotor activity. Microinjectionof deltorphin into the vPAG produced a consistent decrease in activity in ratspretreated with morphine. This decrease in activity was caused by a drasticchange in behavior from exploring and grooming to crouching and lying along theedge of the cage. In contrast, microinjection of deltorphin produced a mildantinociception that was not altered in a consistent manner by prior morphineadministration.</p><p>MORagonists such as morphine are the most effective treatment for pain. Thedescending modulatory system that runs from the PAG to rostral ventromedialmedulla (RVM) to spinal dorsal horn plays an important role in theantinociceptive effects of both MOR and DOR agonists [<xref ref-type="bibr" rid="B9">9</xref>, <xref ref-type="bibr" rid="B25">25</xref>&#x02013;<xref ref-type="bibr" rid="B28">28</xref>]. The antinociceptionproduced by microinjection of DOR agonists into the PAG is weak compared tomorphine administration [<xref ref-type="bibr" rid="B9">9</xref>, <xref ref-type="bibr" rid="B10">10</xref>]. However, DORs are located in the PAG [<xref ref-type="bibr" rid="B13">13</xref>] and these receptorsappear to move from the cytoplasm to the plasma membrane following stress [<xref ref-type="bibr" rid="B14">14</xref>]. The density of DORs onthe membrane has also beenshown to increase in spinal neurons following chronic exposure to morphine [<xref ref-type="bibr" rid="B11">11</xref>, <xref ref-type="bibr" rid="B12">12</xref>].</p><p>The present data showthat microinjection of deltorphin into the vPAG had modest effects onnociception. Rats pretreated with 10 mg/kg of morphine showed a slighthyperalgesia compared to saline-pretreated rats injected with deltorphin intothe vPAG. This effect seems to be dose and test dependent. Rats pretreated with20 mg/kg of morphine showed a slight increase in hot-plate latency followingdeltorphin microinjection. No changes in nociception were evident on theformalin test. The lack of effect of deltorphin in modulating nociception issurprising given that spinal administration of deltorphin following chronicmorphine administration produces antinociception [<xref ref-type="bibr" rid="B11">11</xref>].</p><p>Thelack of a consistent change in nociception following deltorphin administrationcould be caused by an inability of the morphine administration procedure tomobilize DORs to the plasma membrane. Although possible, this explanation seemsunlikely given that a decrease in activity was produced by microinjection ofdeltorphin into the PAG. Moreover, we used two different procedures to inducetolerance (repeated injections and continuous administration) that closelymatch previous studies reporting changes in DORs [<xref ref-type="bibr" rid="B11">11</xref>, <xref ref-type="bibr" rid="B12">12</xref>, <xref ref-type="bibr" rid="B18">18</xref>]. Finally,mobilization of DORs to the plasma membrane is associated with morphinetolerance and the rats in the present study showed clear signs of tolerance tothe antinociceptive effects of morphine.</p><p>				<italic>In vitro</italic> electrophysiologicalrecordings reveal DOR-mediated inhibition of GABAergic IPSCs in tissue frommice pretreated with morphine [<xref ref-type="bibr" rid="B18">18</xref>], but no effect of DORagonists in PAG slices from animals that have not been exposed to morphine [<xref ref-type="bibr" rid="B15">15</xref>&#x02013;<xref ref-type="bibr" rid="B17">17</xref>]. This inhibition of GABA inputis similar to the effect produced by administration of MOR agonists into thePAG [<xref ref-type="bibr" rid="B29">29</xref>]. These data suggestthat microinjection of DOR agonists into the PAG of morphine tolerant ratsshould produce antinociception. However, the present data show no consistentantinociceptive effect following deltorphin microinjection into the PAG ofmorphine tolerant rats.</p><p>Incontrast, microinjection of deltorphin into the vPAG of morphine pretreated-ratscaused a clear and consistent decrease in locomotor activity. Acuteadministration of morphine into the vPAG also produces a decrease in activity [<xref ref-type="bibr" rid="B4">4</xref>]. Thus, it appears thatDORs compensate for the locomotor, but not the antinociceptive effectsassociated with morphine tolerance in the vPAG. The immobility produced bymorphine microinjection into the vPAG appears to be part of a defensivefreezing response [<xref ref-type="bibr" rid="B30">30</xref>&#x02013;<xref ref-type="bibr" rid="B33">33</xref>]. However, the decreasein activity produced by microinjection of deltorphin into the vPAG reportedhere does not appear to be caused by fear-induced freezing. Microinjection ofdeltorphin caused rats to crouch and lay along the edge of the cage as if therats were ill or dysphoric. This effect appears to be consistent with previousresearch showing that deep tissue pain sufficient to induce recuperativebehavior activates vPAG neurons [<xref ref-type="bibr" rid="B34">34</xref>]. Given that stressincreases the density of DORs on the plasma membrane [<xref ref-type="bibr" rid="B14">14</xref>], activation of thesereceptors may contribute to recuperative behavior.</p><p>One hypothesis is thatthe recuperative behavior mediated by the vPAG is part of a coordinated response triggered bysevere hemorrhage that includes hypotension. Severe blood loss has been shownto activate neurons in the vPAG [<xref ref-type="bibr" rid="B35">35</xref>], and inactivation ofthe vPAG [<xref ref-type="bibr" rid="B2">2</xref>, <xref ref-type="bibr" rid="B36">36</xref>]or microinjection of the DOR antagonist naltrindole into the PAG [<xref ref-type="bibr" rid="B37">37</xref>] blocks the hypotensionproduced by hemorrhage. Future studies are needed to determine whetheractivation of DORs in the PAG alters blood pressure.</p></sec><sec sec-type="section" id="sec5"><title>5. Conclusion</title><p>The decrease inlocomotor activity caused by microinjection of deltorphin into the vPAG ofmorphine tolerant rats is consistent with previous data showing that DORdensity on the plasma membrane increases following chronic morphineadministration. PAG DORs could contribute to morphine tolerance [<xref ref-type="bibr" rid="B38">38</xref>&#x02013;<xref ref-type="bibr" rid="B40">40</xref>], behavioral changesrelated to stress [<xref ref-type="bibr" rid="B14">14</xref>], or hypovolemic shock [<xref ref-type="bibr" rid="B35">35</xref>, <xref ref-type="bibr" rid="B37">37</xref>], butdo not appear to contribute to antinociception. That is microinjection ofdeltorphin into the PAG did not produce antinociception regardless of howtolerance was induced (repeated injections or continuous administration), testused to assess nociception (hot plate, tail flick, and formalin tests), or testtimes (20 and 50 minutes).</p></sec></body><back><ack><title>Acknowledgments</title><p>Theauthors thank Cecilea Clayton and Erin Fossum Bobeck for technical assistance. Thisstudy was supported in part by NIH Grant DA015498 and by funds provided formedical and biological research by the State of Washington Initiative Measure no. 171. Morphine sulfate was a gift from the National Institute on Drug Abuse (NIDA).</p></ack><ref-list><ref id="B1"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cavun</surname><given-names>S</given-names></name><name><surname>Goktalay</surname><given-names>G</given-names></name><name><surname>Millington</surname><given-names>WR</given-names></name></person-group><article-title>The hypotension evoked by visceral nociception is mediated by delta opioid receptors in the periaqueductal gray</article-title><source><italic>Brain Research</italic></source><year>2004</year><volume>1019</volume><issue>1-2</issue><fpage>237</fpage><lpage>245</lpage><pub-id pub-id-type="pmid">15306258</pub-id></element-citation></ref><ref id="B2"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cavun</surname><given-names>S</given-names></name><name><surname>Millington</surname><given-names>WR</given-names></name></person-group><article-title>Evidence that hemorrhagic hypotension is mediated by the ventrolateral periaqueductal gray region</article-title><source><italic>American Journal of Physiology</italic></source><year>2001</year><volume>281</volume><issue>3</issue><fpage>R747</fpage><lpage>R752</lpage><pub-id pub-id-type="pmid">11506988</pub-id></element-citation></ref><ref id="B3"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Keay</surname><given-names>KA</given-names></name><name><surname>Crowfoot</surname><given-names>LJ</given-names></name><name><surname>Floyd</surname><given-names>NS</given-names></name><name><surname>Henderson</surname><given-names>LA</given-names></name><name><surname>Christie</surname><given-names>MJ</given-names></name><name><surname>Bandler</surname><given-names>R</given-names></name></person-group><article-title>Cardiovascular effects of microinjections of opioid agonists into the &#x02018;Depressor Region&#x02019; of the ventrolateral periaqueductal gray region</article-title><source><italic>Brain Research</italic></source><year>1997</year><volume>762</volume><issue>1-2</issue><fpage>61</fpage><lpage>71</lpage><pub-id pub-id-type="pmid">9262159</pub-id></element-citation></ref><ref id="B4"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Morgan</surname><given-names>MM</given-names></name><name><surname>Whitney</surname><given-names>PK</given-names></name><name><surname>Gold</surname><given-names>MS</given-names></name></person-group><article-title>Immobility and flight associated with antinociception produced by activation of the ventral and lateral/dorsal regions of the rat periaqueductal gray</article-title><source><italic>Brain Research</italic></source><year>1998</year><volume>804</volume><issue>1</issue><fpage>159</fpage><lpage>166</lpage><pub-id pub-id-type="pmid">9729359</pub-id></element-citation></ref><ref id="B5"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Widdowson</surname><given-names>PS</given-names></name><name><surname>Griffiths</surname><given-names>EC</given-names></name><name><surname>Slater</surname><given-names>P</given-names></name></person-group><article-title>Body temperature effects of opioids administered into the periaqueductal grey area of rat brain</article-title><source><italic>Regulatory Peptides</italic></source><year>1983</year><volume>7</volume><issue>3</issue><fpage>259</fpage><lpage>267</lpage><pub-id pub-id-type="pmid">6320316</pub-id></element-citation></ref><ref id="B6"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bernal</surname><given-names>SA</given-names></name><name><surname>Morgan</surname><given-names>MM</given-names></name><name><surname>Craft</surname><given-names>RM</given-names></name></person-group><article-title>PAG mu opioid receptor activation underlies sex differences in morphine antinociception</article-title><source><italic>Behavioural Brain Research</italic></source><year>2007</year><volume>177</volume><issue>1</issue><fpage>126</fpage><lpage>133</lpage><pub-id pub-id-type="pmid">17118467</pub-id></element-citation></ref><ref id="B7"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bodnar</surname><given-names>RJ</given-names></name><name><surname>Williams</surname><given-names>CL</given-names></name><name><surname>Lee</surname><given-names>SJ</given-names></name><name><surname>Pasternak</surname><given-names>GW</given-names></name></person-group><article-title>Role of <italic>&#x003bc;</italic><sub>1</sub>-opiate receptors in supraspinal opiate analgesia: a microinjection study</article-title><source><italic>Brain Research</italic></source><year>1988</year><volume>447</volume><issue>1</issue><fpage>25</fpage><lpage>34</lpage><pub-id pub-id-type="pmid">2838129</pub-id></element-citation></ref><ref id="B8"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Meyer</surname><given-names>PJ</given-names></name><name><surname>Fossum</surname><given-names>EN</given-names></name><name><surname>Ingram</surname><given-names>SL</given-names></name><name><surname>Morgan</surname><given-names>MM</given-names></name></person-group><article-title>Analgesic tolerance to microinjection of the <italic>&#x003bc;</italic>-opioid agonist DAMGO into the ventrolateral periaqueductal gray</article-title><source><italic>Neuropharmacology</italic></source><year>2007</year><volume>52</volume><issue>8</issue><fpage>1580</fpage><lpage>1585</lpage><pub-id pub-id-type="pmid">17445843</pub-id></element-citation></ref><ref id="B9"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ossipov</surname><given-names>MH</given-names></name><name><surname>Kovelowski</surname><given-names>CJ</given-names></name><name><surname>Nichols</surname><given-names>ML</given-names></name><name><surname>Hruby</surname><given-names>VJ</given-names></name><name><surname>Porreca</surname><given-names>F</given-names></name></person-group><article-title>Characterization of supraspinal antinociceptive actions of opioid delta agonists in the rat</article-title><source><italic>Pain</italic></source><year>1995</year><volume>62</volume><issue>3</issue><fpage>287</fpage><lpage>293</lpage><pub-id pub-id-type="pmid">8657428</pub-id></element-citation></ref><ref id="B10"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rossi</surname><given-names>GC</given-names></name><name><surname>Pasternak</surname><given-names>GW</given-names></name><name><surname>Bodnar</surname><given-names>RJ</given-names></name></person-group><article-title>						<italic>&#x003bc;</italic> and <italic>&#x003b4;</italic> opioid synergy between the periaqueductal gray and the rostro-ventral medulla</article-title><source><italic>Brain Research</italic></source><year>1994</year><volume>665</volume><issue>1</issue><fpage>85</fpage><lpage>93</lpage><pub-id pub-id-type="pmid">7882023</pub-id></element-citation></ref><ref id="B11"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cahill</surname><given-names>CM</given-names></name><name><surname>Morinville</surname><given-names>A</given-names></name><name><surname>Lee</surname><given-names>M-C</given-names></name><name><surname>Vincent</surname><given-names>J-P</given-names></name><name><surname>Collier</surname><given-names>B</given-names></name><name><surname>Beaudet</surname><given-names>A</given-names></name></person-group><article-title>Prolonged morphine treatment targets <italic>&#x003b4;</italic> opioid receptors to neuronal plasma membranes and enhances <italic>&#x003b4;</italic>-mediated antinociception</article-title><source><italic>The Journal of Neuroscience</italic></source><year>2001</year><volume>21</volume><issue>19</issue><fpage>7598</fpage><lpage>7607</lpage><pub-id pub-id-type="pmid">11567050</pub-id></element-citation></ref><ref id="B12"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Morinville</surname><given-names>A</given-names></name><name><surname>Cahill</surname><given-names>CM</given-names></name><name><surname>Esdaile</surname><given-names>MJ</given-names></name><etal/></person-group><article-title>Regulation of <italic>&#x003b4;</italic>-opioid receptor trafficking via <italic>&#x003bc;</italic>-opioid receptor stimulation: evidence from <italic>&#x003bc;</italic>-opioid receptor knock-out mice</article-title><source><italic>The Journal of Neuroscience</italic></source><year>2003</year><volume>23</volume><issue>12</issue><fpage>4888</fpage><lpage>4898</lpage><pub-id pub-id-type="pmid">12832511</pub-id></element-citation></ref><ref id="B13"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Commons</surname><given-names>KG</given-names></name><name><surname>Beck</surname><given-names>SG</given-names></name><name><surname>Rudoy</surname><given-names>C</given-names></name><name><surname>Van Bockstaele</surname><given-names>EJ</given-names></name></person-group><article-title>Anatomical evidence for presynaptic modulation by the delta opioid receptor in the ventrolateral periaqueductal gray of the rat</article-title><source><italic>The Journal of Comparative Neurology</italic></source><year>2001</year><volume>430</volume><issue>2</issue><fpage>200</fpage><lpage>208</lpage><pub-id pub-id-type="pmid">11135256</pub-id></element-citation></ref><ref id="B14"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Commons</surname><given-names>KG</given-names></name></person-group><article-title>Translocation of presynaptic delta opioid receptors in the ventrolateral periaqueductal gray after swim stress</article-title><source><italic>The Journal of Comparative Neurology</italic></source><year>2003</year><volume>464</volume><issue>2</issue><fpage>197</fpage><lpage>207</lpage><pub-id pub-id-type="pmid">12898612</pub-id></element-citation></ref><ref id="B15"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chieng</surname><given-names>B</given-names></name><name><surname>Christie</surname><given-names>MJ</given-names></name></person-group><article-title>Inhibition by opioids acting on <italic>&#x003bc;</italic>-receptors of GABAergic and glutamatergic postsynaptic potentials in single rat periaqueductal gray neurones in vitro</article-title><source><italic>British Journal of Pharmacology</italic></source><year>1994</year><volume>113</volume><issue>1</issue><fpage>303</fpage><lpage>309</lpage><pub-id pub-id-type="pmid">7812626</pub-id></element-citation></ref><ref id="B16"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Connor</surname><given-names>M</given-names></name><name><surname>Christie</surname><given-names>MJ</given-names></name></person-group><article-title>Modulation of Ca<sup>2+</sup> channel currents of acutely dissociated rat periaqueductal grey neurons</article-title><source><italic>The Journal of Physiology</italic></source><year>1998</year><volume>509</volume><issue>1</issue><fpage>47</fpage><lpage>58</lpage><pub-id pub-id-type="pmid">9547380</pub-id></element-citation></ref><ref id="B17"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vaughan</surname><given-names>CW</given-names></name><name><surname>Christie</surname><given-names>MJ</given-names></name></person-group><article-title>Presynaptic inhibitory action of opioids on synaptic transmission in the rat periaqueductal grey in vitro</article-title><source><italic>The Journal of Physiology</italic></source><year>1997</year><volume>498, part 2</volume><fpage>463</fpage><lpage>472</lpage><pub-id pub-id-type="pmid">9032693</pub-id></element-citation></ref><ref id="B18"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hack</surname><given-names>SP</given-names></name><name><surname>Bagley</surname><given-names>EE</given-names></name><name><surname>Chieng</surname><given-names>BCH</given-names></name><name><surname>Christie</surname><given-names>MJ</given-names></name></person-group><article-title>Induction of <italic>&#x003b4;</italic>-opioid receptor function in the midbrain after chronic morphine treatment</article-title><source><italic>The Journal of Neuroscience</italic></source><year>2005</year><volume>25</volume><issue>12</issue><fpage>3192</fpage><lpage>3198</lpage><pub-id pub-id-type="pmid">15788776</pub-id></element-citation></ref><ref id="B19"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cahill</surname><given-names>CM</given-names></name><name><surname>McClellan</surname><given-names>KA</given-names></name><name><surname>Morinville</surname><given-names>A</given-names></name><etal/></person-group><article-title>Immunohistochemical distribution of delta opioid receptors in the rat central nervous system: evidence for somatodendritic labeling and antigen-specific cellular compartmentalization</article-title><source><italic>The Journal of Comparative Neurology</italic></source><year>2001</year><volume>440</volume><issue>1</issue><fpage>65</fpage><lpage>84</lpage><pub-id pub-id-type="pmid">11745608</pub-id></element-citation></ref><ref id="B20"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dubuisson</surname><given-names>D</given-names></name><name><surname>Dennis</surname><given-names>SG</given-names></name></person-group><article-title>The formalin test: a quantitative study of the analgesic effects of morphine, meperidine, and brain stem stimulation in rats and cats</article-title><source><italic>Pain</italic></source><year>1977</year><volume>4</volume><issue>2</issue><fpage>161</fpage><lpage>174</lpage><pub-id pub-id-type="pmid">564014</pub-id></element-citation></ref><ref id="B21"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gamble</surname><given-names>GD</given-names></name><name><surname>Milne</surname><given-names>RJ</given-names></name></person-group><article-title>Repeated exposure to sham testing procedures reduces reflex withdrawal and hot-plate latencies: attenuation of tonic descending inhibition?</article-title><source><italic>Neuroscience Letters</italic></source><year>1989</year><volume>96</volume><issue>3</issue><fpage>312</fpage><lpage>317</lpage><pub-id pub-id-type="pmid">2717057</pub-id></element-citation></ref><ref id="B22"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lane</surname><given-names>DA</given-names></name><name><surname>Morgan</surname><given-names>MM</given-names></name></person-group><article-title>Antinociceptive tolerance to morphine from repeated nociceptive testing in the rat</article-title><source><italic>Brain Research</italic></source><year>2005</year><volume>1047</volume><issue>1</issue><fpage>65</fpage><lpage>71</lpage><pub-id pub-id-type="pmid">15878767</pub-id></element-citation></ref><ref id="B23"><label>23</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Paxinos</surname><given-names>G</given-names></name><name><surname>Watson</surname><given-names>SJ</given-names></name></person-group><source><italic>The Rat Brain, in Stereotaxic Coordinates</italic></source><year>2005</year><edition>2nd edition</edition><publisher-loc>Sydney, Australia</publisher-loc><publisher-name>Academic Press</publisher-name></element-citation></ref><ref id="B24"><label>24</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Depaulis</surname><given-names>A</given-names></name><name><surname>Bandler</surname><given-names>R</given-names></name></person-group><source><italic>The Midbrain Periaqueductal Gray Matter: Functional, Anatomical, and Neurochemical Organization</italic></source><year>1991</year><publisher-loc>New York, NY, USA</publisher-loc><publisher-name>Plenum Press</publisher-name></element-citation></ref><ref id="B25"><label>25</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hurley</surname><given-names>RW</given-names></name><name><surname>Grabow</surname><given-names>TS</given-names></name><name><surname>Tallarida</surname><given-names>RJ</given-names></name><name><surname>Hammond</surname><given-names>DL</given-names></name></person-group><article-title>Interaction between medullary and spinal <italic>&#x003b4;</italic><sub>1</sub> and <italic>&#x003b4;</italic><sub>2</sub> opioid receptors in the production of antinociception in the rat</article-title><source><italic>Journal of Pharmacology and Experimental Therapeutics</italic></source><year>1999</year><volume>289</volume><issue>2</issue><fpage>993</fpage><lpage>999</lpage><pub-id pub-id-type="pmid">10215679</pub-id></element-citation></ref><ref id="B26"><label>26</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jensen</surname><given-names>TS</given-names></name><name><surname>Yaksh</surname><given-names>TL</given-names></name></person-group><article-title>I. Comparison of antinociceptive action of morphine in the periaqueductal gray, medial and paramedial medulla in rat</article-title><source><italic>Brain Research</italic></source><year>1986</year><volume>363</volume><issue>1</issue><fpage>99</fpage><lpage>113</lpage><pub-id pub-id-type="pmid">3004644</pub-id></element-citation></ref><ref id="B27"><label>27</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lane</surname><given-names>DA</given-names></name><name><surname>Patel</surname><given-names>PA</given-names></name><name><surname>Morgan</surname><given-names>MM</given-names></name></person-group><article-title>Evidence for an intrinsic mechanism of antinociceptive tolerance within the ventrolateral periaqueductal gray of rats</article-title><source><italic>Neuroscience</italic></source><year>2005</year><volume>135</volume><issue>1</issue><fpage>227</fpage><lpage>234</lpage><pub-id pub-id-type="pmid">16084660</pub-id></element-citation></ref><ref id="B28"><label>28</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Thorat</surname><given-names>SN</given-names></name><name><surname>Hammond</surname><given-names>DL</given-names></name></person-group><article-title>Modulation of nociception by microinjection of <italic>Delta</italic>-1 and <italic>Delta</italic>-2 opioid receptor ligands in the ventromedial medulla of the rat</article-title><source><italic>Journal of Pharmacology and Experimental Therapeutics</italic></source><year>1997</year><volume>283</volume><issue>3</issue><fpage>1185</fpage><lpage>1192</lpage><pub-id pub-id-type="pmid">9399992</pub-id></element-citation></ref><ref id="B29"><label>29</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vaughan</surname><given-names>CW</given-names></name><name><surname>Ingram</surname><given-names>SL</given-names></name><name><surname>Connor</surname><given-names>MA</given-names></name><name><surname>Christie</surname><given-names>MJ</given-names></name></person-group><article-title>How opioids inhibit GABA-mediated neurotransmission</article-title><source><italic>Nature</italic></source><year>1997</year><volume>390</volume><issue>6660</issue><fpage>611</fpage><lpage>614</lpage><pub-id pub-id-type="pmid">9403690</pub-id></element-citation></ref><ref id="B30"><label>30</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Fanselow</surname><given-names>MS</given-names></name></person-group><person-group person-group-type="editor"><name><surname>Depaulis</surname><given-names>A</given-names></name><name><surname>Bandler</surname><given-names>R</given-names></name></person-group><article-title>The midbrain periaqueductal gray as a coordinator of action in response to fear and anxiety</article-title><source><italic>The Midbrain Periaqueductal Gray Matter: Functional, Anatomical, and Neurochemical Organization</italic></source><year>1991</year><publisher-loc>New York, NY, USA</publisher-loc><publisher-name>Plenum Press</publisher-name><fpage>151</fpage><lpage>173</lpage></element-citation></ref><ref id="B31"><label>31</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Helmstetter</surname><given-names>FJ</given-names></name><name><surname>Landeira-Fernandez</surname><given-names>J</given-names></name></person-group><article-title>Conditional hypoalgesia is attenuated by Naltrexone applied to the periaqueductal gray</article-title><source><italic>Brain Research</italic></source><year>1990</year><volume>537</volume><issue>1-2</issue><fpage>88</fpage><lpage>92</lpage><pub-id pub-id-type="pmid">1964843</pub-id></element-citation></ref><ref id="B32"><label>32</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Morgan</surname><given-names>MM</given-names></name><name><surname>Carrive</surname><given-names>P</given-names></name></person-group><article-title>Activation of the ventrolateral periaqueductal gray reduces locomotion but not mean arterial pressure in awake, freely moving rats</article-title><source><italic>Neuroscience</italic></source><year>2001</year><volume>102</volume><issue>4</issue><fpage>905</fpage><lpage>910</lpage><pub-id pub-id-type="pmid">11182252</pub-id></element-citation></ref><ref id="B33"><label>33</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Walker</surname><given-names>P</given-names></name><name><surname>Carrive</surname><given-names>P</given-names></name></person-group><article-title>Role of ventrolateral periaqueductal gray neurons in the behavioral and cardiovascular responses to contextual conditioned fear and poststress recovery</article-title><source><italic>Neuroscience</italic></source><year>2003</year><volume>116</volume><issue>3</issue><fpage>897</fpage><lpage>912</lpage><pub-id pub-id-type="pmid">12573728</pub-id></element-citation></ref><ref id="B34"><label>34</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Keay</surname><given-names>KA</given-names></name><name><surname>Bandler</surname><given-names>R</given-names></name></person-group><article-title>Deep and superficial noxious stimulation increases Fos-like immunoreactivity in different regions of the midbrain periaqueductal grey of the rat</article-title><source><italic>Neuroscience Letters</italic></source><year>1993</year><volume>154</volume><issue>1-2</issue><fpage>23</fpage><lpage>26</lpage><pub-id pub-id-type="pmid">8361643</pub-id></element-citation></ref><ref id="B35"><label>35</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vagg</surname><given-names>DJ</given-names></name><name><surname>Bandler</surname><given-names>R</given-names></name><name><surname>Keay</surname><given-names>KA</given-names></name></person-group><article-title>Hypovolemic shock: critical involvement of a projection from the ventrolateral periaqueductal gray to the caudal midline medulla</article-title><source><italic>Neuroscience</italic></source><year>2008</year><volume>152</volume><issue>4</issue><fpage>1099</fpage><lpage>1109</lpage><pub-id pub-id-type="pmid">18343586</pub-id></element-citation></ref><ref id="B36"><label>36</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dean</surname><given-names>C</given-names></name></person-group><article-title>Hemorrhagic sympathoinhibition mediated through the periaqueductal gray in the rat</article-title><source><italic>Neuroscience Letters</italic></source><year>2004</year><volume>354</volume><issue>1</issue><fpage>79</fpage><lpage>83</lpage><pub-id pub-id-type="pmid">14698486</pub-id></element-citation></ref><ref id="B37"><label>37</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cavun</surname><given-names>S</given-names></name><name><surname>Resch</surname><given-names>GE</given-names></name><name><surname>Evec</surname><given-names>AD</given-names></name><name><surname>Rapacon-Baker</surname><given-names>MM</given-names></name><name><surname>Millington</surname><given-names>WR</given-names></name></person-group><article-title>Blockade of delta opioid receptors in the ventrolateral periaqueductal gray region inhibits the fall in arterial pressure evoked by hemorrhage</article-title><source><italic>Journal of Pharmacology and Experimental Therapeutics</italic></source><year>2001</year><volume>297</volume><issue>2</issue><fpage>612</fpage><lpage>619</lpage><pub-id pub-id-type="pmid">11303050</pub-id></element-citation></ref><ref id="B38"><label>38</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Abdelhamid</surname><given-names>EE</given-names></name><name><surname>Sultana</surname><given-names>M</given-names></name><name><surname>Portoghese</surname><given-names>PS</given-names></name><name><surname>Takemori</surname><given-names>AE</given-names></name></person-group><article-title>Selective blockage of delta opioid receptors prevents the development of morphine tolerance and dependence in mice</article-title><source><italic>Journal of Pharmacology and Experimental Therapeutics</italic></source><year>1991</year><volume>258</volume><issue>1</issue><fpage>299</fpage><lpage>303</lpage><pub-id pub-id-type="pmid">1649297</pub-id></element-citation></ref><ref id="B39"><label>39</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Abul-Husn</surname><given-names>NS</given-names></name><name><surname>Sutak</surname><given-names>M</given-names></name><name><surname>Milne</surname><given-names>B</given-names></name><name><surname>Jhamandas</surname><given-names>K</given-names></name></person-group><article-title>Augmentation of spinal morphine analgesia and inhibition of tolerance by low doses of <italic>&#x003bc;</italic>- and <italic>&#x003b4;</italic>-opioid receptor antagonists</article-title><source><italic>British Journal of Pharmacology</italic></source><year>2007</year><volume>151</volume><issue>6</issue><fpage>877</fpage><lpage>887</lpage><pub-id pub-id-type="pmid">17502848</pub-id></element-citation></ref><ref id="B40"><label>40</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gomes</surname><given-names>I</given-names></name><name><surname>Gupta</surname><given-names>A</given-names></name><name><surname>Filipovska</surname><given-names>J</given-names></name><name><surname>Szeto</surname><given-names>HH</given-names></name><name><surname>Pintar</surname><given-names>JE</given-names></name><name><surname>Devi</surname><given-names>LA</given-names></name></person-group><article-title>A role for heterodimerization of <italic>&#x003bc;</italic> and <italic>&#x003b4;</italic> opiate receptors in enhancing morphine analgesia</article-title><source><italic>Proceedings of the National Academy of Sciences of the United States of America</italic></source><year>2004</year><volume>101</volume><issue>14</issue><fpage>5135</fpage><lpage>5139</lpage><pub-id pub-id-type="pmid">15044695</pub-id></element-citation></ref></ref-list></back><floats-group><fig id="fig1" position="float"><label>Figure 1</label><caption><p>Tolerance toantinociception develops with repeated injections of morphine. The hot-platelatency following morphine administration on trial 7 was significantly lessthan on trial 1 for the morphine-treated groups (F(1, 39)  =  31.38, <italic>P</italic>  &#x0003c;  .01). Antinociception was still evident with the administration of large dosesof morphine (10 and 20 mg/kg), but not as pronounced as on trial 1. Largesample sizes were used for most groups (<italic>N</italic>  =  19, 5, 19, and 17 for ratspretreated with saline and morphine at 5, 10, and 20 mg/kg, resp.) becausesubsets of these rats were subsequently tested using either the formalin testor repeated hot-plate tests.</p></caption><graphic xlink:href="NP2009-516328.001"/></fig><fig id="fig2" position="float"><label>Figure 2</label><caption><p>Changes innociception following microinjection of deltorphin into the vPAG. Nociceptionwas assessed 20 and 50 minutes after deltorphin microinjection into the vPAG ofrats made tolerant to morphine. Pretreatment with morphine produced a slight decreasein hot-plate latency in rats made tolerant to 10 mg/kg of morphine compared tothe slight increase in rats made tolerant to 20 mg/kg of morphine, althoughneither of these changes differed significantly from the effects of deltorphinadministration in saline-pretreated controls. All rats were tested on the hotplate 20 minutes after deltorphin microinjection (see sample sizes in thecaption of <xref ref-type="fig" rid="fig1">Figure 1</xref>), but only a subset was tested at 50 minutes for the saline (<italic>N</italic>  =  9), 5(<italic>N</italic>  =  5), 10 (<italic>N</italic>  =  10), and 20 (<italic>N</italic>  =  8) mg/kg morphine groups.</p></caption><graphic xlink:href="NP2009-516328.002"/></fig><fig id="fig3" position="float"><label>Figure 3</label><caption><p>Decrease inlocomotion following microinjection of deltorphin into the vPAG. Microinjectionof deltorphin (1 <italic>&#x003bc;</italic>g/0.5 <italic>&#x003bc;</italic>l) into the vPAG caused a decrease in locomotion inrats pretreated with morphine (<italic>N</italic>  =  13 and 9 for rats pretreated with 10 and 20 mg/kg) compared to rats pretreated with saline (<italic>N</italic>  =  11). This decrease inactivity is caused by a change in normal behavior to lying and crouching in thecage following deltorphin administration (see <xref ref-type="table" rid="tab1">Table 1</xref>).</p></caption><graphic xlink:href="NP2009-516328.003"/></fig><fig id="fig4" position="float"><label>Figure 4</label><caption><p>No change innociception following deltorphin microinjection into the vPAG in rats treatedwith continuous morphine. Rats implanted with morphine pellets 3 days prior tothis test had higher baseline hot-plate latency than rats implanted withplacebo pellets indicating that tolerance to the antinociceptive effects was not complete. Microinjection of deltorphin into the vPAG caused an increase in hot-platelatency in rats with placebo pellets (<italic>N</italic>  =  5), but did not increase the hot-platelatency for rats with morphine pellets (<italic>N</italic>  =  5) above the baseline latency. Thatis, there was no additional antinociception by injecting deltorphin into thevPAG of rats receiving morphine.</p></caption><graphic xlink:href="NP2009-516328.004"/></fig><table-wrap id="tab1" position="float"><label>Table 1</label><caption><p>Percentage ofrats showing normal and abnormal behavior following deltorphin microinjectioninto the vPAG in morphine-pretreated rats.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" colspan="3" rowspan="1">Crouching/lying</th></tr><tr><th align="left" rowspan="1" colspan="1">Pretreatment</th><th align="center" rowspan="1" colspan="1">25&#x02013;39 minutes</th><th align="center" rowspan="1" colspan="1">40&#x02013;54 minutes</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Saline</td><td align="center" rowspan="1" colspan="1">0% (0/6)</td><td align="center" rowspan="1" colspan="1">0% (0/6)</td></tr><tr><td align="left" rowspan="1" colspan="1">Morphine 10 mg</td><td align="center" rowspan="1" colspan="1">20% (1/5)</td><td align="center" rowspan="1" colspan="1">67% (6/9)</td></tr><tr><td align="left" rowspan="1" colspan="1">Morphine 20 mg</td><td align="center" rowspan="1" colspan="1">36% (4/11)</td><td align="center" rowspan="1" colspan="1">40% (6/15)</td></tr></tbody></table><table-wrap-foot><fn><p>Note: sample sizes are shown in parentheses.</p></fn></table-wrap-foot></table-wrap></floats-group></article>